Resources
About Us
Home Report
Store
Digital Pathology Market
Digital Pathology Market by Offering (Hardware [Scanner, Tissue Microarray], Software [Information Management, Image Analysis], Service), Application (Diagnostic, Drug Discovery, Training), End User (Hospital, Academic Institute) - Global Forecast to 2030
Report ID:MRHC - 104749 Pages: 185 Jun-2024 Formats*: PDF Category: Healthcare Delivery: 24 to 72 HoursThe Digital Pathology Market is poised to reach $1.86 billion by 2030, exhibiting a CAGR of 8.7% from 2024 to 2030.
Digital pathology entails the interpretation and management of pathology information derived from digitized glass slides. It has become a mainstream choice for routine diagnostics and drug development. The adoption of digital pathology has surged owing to its diverse advantages, such as real-time sharing of video streams and digital images. Moreover, the integration of machine learning (ML) allows image assessments beyond traditional histopathology by connecting AI with clinical data.
Furthermore, the rising adoption of digital pathology has led to the emergence of virtual pathology, creating new opportunities for teleconsulting. Moreover, computer-aided diagnosis by digital images produces more precise and accurate results than a traditional microscope offering. The technology is gaining prominence due to growing requirements in anatomical pathology applications for quantitative image analysis. These emerging imaging tools enable pathologists to conduct more consistent and accurate diagnoses.
Increasing Adoption of Digital Pathology Solutions to Enhance Lab Efficiency
Digital pathology enables pathologists to collaborate and work remotely on cases by improving the accuracy of diagnostic techniques and allowing the sharing of digital images beyond geographical limitations. Before the outbreak of COVID-19, the adoption of digital pathology was extremely low due to stringent federal regulations of the U.S. FDA. The adoption increased due to the relaxation of FDA requirements for validating and approving digital pathology-related technology to meet the increased demand during the pandemic. Furthermore, the Centers for Medicare & Medicaid Services waived the Clinical Laboratory Improvement Amendments restrictions, allowing pathologists to use digital pathology platforms from their homes. Hence, the COVID-19 pandemic supported the adoption of digital pathology, allowing pathologists and physicians to deliver remote support & care to patients.
According to the data released by Pathcore Inc. (Canada) in January 2020, the number of pathologists in the U.S. is declining. Amid the decline in the number of pathologists and the rise in workloads, many pathologists are adopting digital pathology tools with AI in their clinical practice. AI allows pathologists to conduct preliminary assessments for high-risk and complex cases and manage the vast amount of data created for improving pathologic classification, diagnosis, and disease predictions.
Click here to: Get Free Sample Copy of this report
Rising Prevalence of Chronic Diseases
According to the Centers for Disease Control and Prevention, chronic diseases such as cancer, diabetes, and cardiovascular diseases are major causes of disability and death in the U.S. and account for USD 4.1 trillion of the nation’s annual healthcare costs. As of July 2022, six in ten adults have a chronic disease in the U.S. and four in ten suffer from two or more chronic diseases.
As per the data published by the WHO, it is expected that by 2030, 1 in six people globally will be more than 60 years old. By 2050, the global population aged 60 and above is likely to increase to nearly 2.1 billion. Additionally, the number of individuals aged 80 or older is expected to reach 426 million between 2020 and 2050. The prevalence of chronic diseases is higher among the elderly population. Thus, the rising aging population and the subsequent increase in cancer & other chronic diseases are expected to drive the demand for more precise and accurate diagnosis, driving the growth of the digital pathology market.
Key Findings in the Global Digital Pathology Market Study:
Based on offering, the hardware segment is expected to account for the largest share of the market in 2024
The large market share of this segment is attributed to the increasing number of laboratories, the rising number of patients requiring in vitro tests, and the growing need for timely and accurate disease treatment. The hardware segment is further subsegmented into tissue microarrays, scanners, and other hardware. The large market share of the hardware segment is attributed to the increased demand for scanners for R&D activities, the rising prevalence of chronic diseases, and the high adoption of digital pathology systems.
Based on application, the disease diagnosis segment is expected to account for the largest share of the market in 2024
The large market share of this segment is attributed to the high burden of chronic diseases, the high adoption of teleconsulting, and the rising awareness about the importance of early disease diagnosis is driving the demand for digital pathology solutions.
Based on end user, in 2024, the hospitals & clinics segment is expected to account for the largest share of the market
The large market share of this segment is attributed to the rising number of hospitals & clinics, the rise in the number of hospitalizations for the treatment of chronic diseases, and the increasing installation of digital pathology systems and tools in the healthcare sector in developed countries. Additionally, strategic collaborations among hospitals and key market players for launching advanced products are expected to drive the market’s growth. For instance, in May 2022, Sectra AB (Sweden) signed an agreement with UniHA, a cooperative of French public hospitals, for Spectra’s digital pathology. This agreement enabled the hospitals to purchase Sectra’s solution without undertaking a public tender process on preconditioned terms and conditions.
Asia-Pacific: Fastest-growing Regional Market
The growth of this regional market is attributed to the increasing geriatric population in countries such as China and India, the rising adoption of advanced healthcare solutions in developing countries, the rising disposable incomes among the population, and the rising awareness about the advantages of digital pathology.
Key Players
The report includes a competitive landscape based on an extensive assessment of the key growth strategies adopted by leading market players between 2020 and 2022. The key players profiled in the digital pathology market report are 3DHISTECH Ltd. (Hungary), Leica Microsystems (a subsidiary of Danaher Corporation) (Germany), Hamamatsu Photonics K.K. (Japan), Nikon Corporation (Japan), Visiopharm A/S (Denmark), Koninklijke Philips N.V.(Netherlands), F. Hoffmann-La Roche Ltd (Switzerland), Glencoe Software, Inc. (U.S.), XIFIN, Inc. (U.S.), and PerkinElmer Inc.(U.S.).
Scope of the Report:
Digital Pathology Market, by Offering
- Hardware
- Slide Scanners
- Bright Field
- Other Scanners
- Tissue Microarray
- Other Hardware
- Slide Scanners
- Software
- Image Analysis Software
- Information Management System
- Other Software
- Services
(Note 1: Other Hardware includes Clinical Microscopes and Accessories.)
(Note 2: Other Software includes Digital Storage Systems, Tissue Microarray Software, and Telepathology Platforms.)
Digital Pathology Market, by Application
- Disease Diagnosis
- Drug Discovery & Development
- Education & Training
- Teleconsultation
Digital Pathology Market, by End User
- Hospitals & Clinics
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- Diagnostic Laboratories
Digital Pathology Market, by Geography
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Rest of Europe (RoE)
- Asia-Pacific (APAC)
- China
- Japan
- India
- Rest of APAC (RoAPAC)
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
Key questions answered in the report:
This study offers a detailed assessment of the digital pathology market and provides the sizes & forecasts for the digital pathology market based on offering, application, and end user. The report also offers the value analysis of various segments and subsegments of the digital pathology market at the regional and country levels.
The global digital pathology market is projected to reach $1.86 billion by 2030, at a CAGR of 8.7% during the forecast period.
Based on offering, in 2024, the hardware segment accounted for the largest share of the digital pathology market. The large market share of this segment is attributed to the increased demand for scanners for R&D activities, the rising prevalence of chronic diseases, and the high adoption of digital pathology systems.
Based on application, the disease diagnosis segment held the major share of the digital pathology market in 2024. The large market share of this segment is attributed to the rise in the geriatric population globally and the high burden of chronic diseases.
The growth of this market is attributed to the high prevalence of cancer, the increasing availability of biomarkers and research on biomarkers, the growing number of clinical trials for oncology drugs, the rising demand for accurate detection of genetic and rare diseases, and the high adoption of teleconsulting. Furthermore, growing interests in precision medicine and emerging economies are expected to offer significant opportunities for the market’s growth.
The major players operating in the digital pathology market include 3DHISTECH Ltd. (Hungary), Leica Microsystems (a subsidiary of Danaher Corporation) (Germany), Hamamatsu Photonics K.K. (Japan), Nikon Corporation (Japan), Visiopharm A/S (Denmark), Koninklijke Philips N.V. (Netherlands), F. Hoffmann-La Roche Ltd (Switzerland), Glencoe Software, Inc. (U.S.), XIFIN, Inc. (U.S.), and PerkinElmer Inc. (U.S.).
Emerging economies such as China and India are projected to offer significant growth opportunities to the market players due to rising hospitalization rates, high prevalence of chronic diseases, increasing purchasing power, rising healthcare spending, and developing healthcare infrastructure.
1. Introduction
1.1. Market Definition
1.2. Market Ecosystem
1.3. Currency
1.4. Key Stakeholders
2. Research Methodology
2.1. Research Process
2.2. Data Collection & Validation
2.2.1. Secondary Research
2.2.2. Primary Research
2.3. Market Assessment
2.3.1. Market Size Estimation
2.3.1.1 Bottom-up Approach
2.3.1.2. Top-down Approach
2.3.1.3. Growth Forecast
2.3.2. Market Share Analysis
2.4. Assumptions for this Study
2.5. Limitations for the Study
3. Executive Summary
4. Market Insights
4.1. Market Overview
4.2. Drivers
4.2.1. Rising Prevalence of Chronic Diseases
4.2.2. Increasing Adoption of Digital Pathology Solutions to Enhance Lab Efficiency
4.2.3. Wider Applications of Digital Pathology in Companion Diagnostics And Drug Development
4.3. Restraints
4.3.1. Lack of Reimbursement for Digital Pathology Services
4.4. Opportunity
4.4.1. Rising Demand for Personalized Medicine
4.4.2. Launch of Affordable Scanners for Private Pathology Practices
4.4.3. Developing Economies
4.5. Challenges
4.5.1. Legal and Regulatory Hurdles in Digital Pathology
4.5.2. Shortage of Trained Pathologists
4.6. Impact of COVID-19 on the Digital Pathology Market
5. Global Digital Pathology Market, by Offering
5.1. Introduction
5.2. Hardware
5.2.1. Slide Scanners
5.2.1.1. Bright Field
5.2.1.2. Other Scanners
5.2.2. Tissue Microarray
5.2.3. Other Hardware (Clinical Microscopes, Accessories)
5.3. Software
5.3.1. Image Analysis Software
5.3.2. Information Management System
5.3.3. Other Software (Digital Storage Systems, Tissue Microarray Software, Telepathology Platforms)
5.4. Services
6. Global Digital Pathology Market, by Application
6.1. Introduction
6.2. Diagnostics
6.3. Drug Discovery & Development
6.4. Education & Training
6.5. Teleconsultation
7. Global Digital Pathology Market, by End User
7.1. Introduction
7.2. Hospitals & Clinics
7.3. Pharmaceutical & Biotechnology Companies
7.4. Academic & Research Institutes
7.5. Diagnostic Laboratories
8. Digital Pathology Market, by Geography
8.1. Introduction
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.3. Europe
8.3.1. Germany
8.3.2. U.K.
8.3.3. France
8.3.4. Italy
8.3.5. Spain
8.3.6. Rest of Europe (RoE)
8.4. Asia-Pacific (APAC)
8.4.1. China
8.4.2. Japan
8.4.3. India
8.4.4. Rest of Asia-Pacific (RoAPAC)
8.5. Latin America (LATAM)
8.5.1. Brazil
8.5.2. Mexico
8.5.3. Rest of Latin America (RoLATAM)
8.6. Middle East & Africa
9. Competitive Landscape
9.1 Introduction
9.2 Key Growth Strategies
9.3 Competitive Benchmarking
9.4. Market Share Analysis (2022)
10. Company Profiles (Business Overview, Financial Overview, Product Portfolio, and Strategic Developments)
10.1. 3DHISTECH Ltd.
10.2. Leica Microsystems (a subsidiary of Danaher Corporation)
10.3. Hamamatsu Photonics K.K.
10.4. Nikon Corporation
10.5. Visiopharm A/S
10.6. Koninklijke Philips N.V.
10.7. F. Hoffmann-La Roche Ltd.
10.8. Glencoe Software, Inc.
10.9. PerkinElmer Inc.
10.10. XIFIN, Inc.
11. Appendix
11.1. Questionnaire
11.2. Available Customization
List of Tables
Table 1 Global Digital Pathology Market Drivers: Impact Analysis (2024–2030)
Table 2 Global Digital Pathology Market Restraints: Impact Analysis (2024–2030)
Table 3 Global Digital Pathology Market Size, by Offering, 2021–2030 (USD Million)
Table 4 Global Digital Pathology Hardware Market Size, by Type, 2021–2030 (USD Million)
Table 5 Global Digital Pathology Hardware Market Size, by Country/Region, 2021–2030 (USD Million)
Table 6 Global Digital Pathology Hardware Market Size for Slide Scanners, 2021–2030 (USD Million)
Table 7 Global Slide Scanners Market Size for Digital Pathology, by Country/Region, 2021–2030 (USD Million)
Table 8 Global Bright Field Slide Scanners Market Size for Digital Pathology, by Country/Region, 2021–2030 (USD Million)
Table 9 Global Other Scanners Market Size for Digital Pathology, by Country/Region, 2021–2030 (USD Million)
Table 10 Global Tissue Microarrays Market Size for Digital Pathology, by Country/Region, 2021–2030 (USD Million)
Table 11 Global Other Hardware Market Size for Digital Pathology, by Country/Region, 2021–2030 (USD Million)
Table 12 Global Digital Pathology Software Market Size, by Type, 2021–2030 (USD Million)
Table 13 Global Digital Pathology Software Market Size, by Country/Region, 2021–2030 (USD Million)
Table 14 Global Digital Pathology Image Analysis Software Market Size, by Country/Region, 2021–2030 (USD Million)
Table 15 Global Digital Pathology Information Management System Market Size, by Country/Region, 2021–2030 (USD Million)
Table 16 Global Digital Pathology Market Size for Other Software, by Country/Region, 2021–2030 (USD Million)
Table 17 Global Digital Pathology Services Market Size, by Country/Region, 2021–2030 (USD Million)
Table 18 Global Digital Pathology Market Size by Application, 2021–2030 (USD Million)
Table 19 Global Digital Pathology Market Size for Diagnostics by Country/Region, 2021–2030 (USD Million)
Table 20 Global Digital Pathology Market Size for Drug Discovery & Development, by Country/Region, 2021–2030 (USD Million)
Table 21 Global Digital Pathology Market Size for Education & Training, by Country/Region, 2021–2030 (USD Million)
Table 22 Global Digital Pathology Market Size for Teleconsultation, by Country/Region, 2021–2030 (USD Million)
Table 23 Global Digital Pathology Market Size by End User, 2021–2030 (USD Million)
Table 24 Global Digital Pathology Market Size for Hospitals & Clinics, by Country/Region, 2021–2030 (USD Million)
Table 25 Global Digital Pathology Market Size for Diagnostic Laboratories, by Country/Region, 2021–2030 (USD Million)
Table 26 Global Digital Pathology Market Size for Research Institutes & Academics, by Country/Region, 2021–2030 (USD Million)
Table 27 Global Digital Pathology Market Size for Pharmaceutical & Biotechnology Companies, by Country/Region, 2021–2030 (USD Million)
Table 28 North America: Digital Pathology Market Size, by Country, 2021–2030 (USD Million)
Table 29 North America: Digital Pathology Market Size, by Offering, 2021–2030 (USD Million)
Table 30 North America: Digital Pathology Market Size for Hardware, by Type 2021–2030 (USD Million)
Table 31 North America: Digital Pathology Market Size for Software, by Type 2021–2030 (USD Million)
Table 32 North America: Digital Pathology Market Size, by Application 2021–2030 (USD Million)
Table 33 North America: Digital Pathology Market Size, by End User 2021–2030 (USD Million)
Table 34 U.S.: Digital Pathology Market Size, by Offering, 2021–2030 (USD Million)
Table 35 U.S.: Digital Pathology Market Size for Hardware, by Type 2021–2030 (USD Million)
Table 36 U.S.: Digital Pathology Market Size for Software, by Type 2021–2030 (USD Million)
Table 37 U.S.: Digital Pathology Market Size, by Application 2021–2030 (USD Million)
Table 38 U.S.: Digital Pathology Market Size, by End User 2021–2030 (USD Million)
Table 39 Canada: Digital Pathology Market Size, by Offering, 2021–2030 (USD Million)
Table 40 Canada: Digital Pathology Market Size for Hardware, by Type 2021–2030 (USD Million)
Table 41 Canada: Digital Pathology Market Size for Software, by Type 2021–2030 (USD Million)
Table 42 Canada: Digital Pathology Market Size, by Application 2021–2030 (USD Million)
Table 43 Canada: Digital Pathology Market Size, by End User 2021–2030 (USD Million)
Table 44 Europe: Digital Pathology Market Size, by Country/Region, 2021–2030 (USD Million)
Table 45 Europe: Digital Pathology Market Size, by Offering, 2021–2030 (USD Million)
Table 46 Europe: Digital Pathology Market Size for Hardware, by Type, 2021–2030 (USD Million)
Table 47 Europe: Digital Pathology Market Size for Software, by Type, 2021–2030 (USD Million)
Table 48 Europe: Digital Pathology Market Size, by Application, 2021–2030 (USD Million)
Table 49 Europe: Digital Pathology Market Size, by End User, 2021–2030 (USD Million)
Table 50 U.K.: Digital Pathology Market Size, by Offering, 2021–2030 (USD Million)
Table 51 U.K.: Digital Pathology Market Size for Hardware, by Type, 2021–2030 (USD Million)
Table 52 U.K.: Digital Pathology Market Size for Software, by Type, 2021–2030 (USD Million)
Table 53 U.K.: Digital Pathology Market Size, by Application, 2021–2030 (USD Million)
Table 54 U.K.: Digital Pathology Market Size, by End User, 2021–2030 (USD Million)
Table 55 Germany: Digital Pathology Market Size, by Offering, 2021–2030 (USD Million)
Table 56 Germany: Digital Pathology Market Size for Hardware, by Type, 2021–2030 (USD Million)
Table 57 Germany: Digital Pathology Market Size for Software, by Type, 2021–2030 (USD Million)
Table 58 Germany: Digital Pathology Market Size, by Application, 2021–2030 (USD Million)
Table 59 Germany: Digital Pathology Market Size, by End User, 2021–2030 (USD Million)
Table 60 France: Digital Pathology Market Size, by Offering, 2021–2030 (USD Million)
Table 61 France: Digital Pathology Market Size for Hardware, by Type, 2021–2030 (USD Million)
Table 62 France: Digital Pathology Market Size for Software, by Type, 2021–2030 (USD Million)
Table 63 France: Digital Pathology Market Size, by Application, 2021–2030 (USD Million)
Table 64 France: Digital Pathology Market Size, by End User 2021–2030 (USD Million)
Table 65 Spain: Digital Pathology Market Size, by Offering, 2021–2030 (USD Million)
Table 66 Spain: Digital Pathology Market Size for Hardware, by Type, 2021–2030 (USD Million)
Table 67 Spain: Digital Pathology Market Size for Software, by Type, 2021–2030 (USD Million)
Table 68 Spain: Digital Pathology Market Size, by Application, 2021–2030 (USD Million)
Table 69 Spain: Digital Pathology Market Size, by End User, 2021–2030 (USD Million)
Table 70 Italy: Digital Pathology Market Size, by Offering, 2021–2030 (USD Million)
Table 71 Italy: Digital Pathology Market Size for Hardware, by Type, 2021–2030 (USD Million)
Table 72 Italy: Digital Pathology Market Size for Software, by Type, 2021–2030 (USD Million)
Table 73 Italy: Digital Pathology Market Size, by Application, 2021–2030 (USD Million)
Table 74 Italy: Digital Pathology Market Size, by End User, 2021–2030 (USD Million)
Table 75 Rest of Europe: Digital Pathology Market Size, by Offering, 2021–2030 (USD Million)
Table 76 Rest of Europe: Digital Pathology Market Size for Hardware, by Type, 2021–2030 (USD Million)
Table 77 Rest of Europe: Digital Pathology Market Size for Software, by Type, 2021–2030 (USD Million)
Table 78 Rest of Europe: Digital Pathology Market Size, by Application, 2021–2030 (USD Million)
Table 79 Rest of Europe: Digital Pathology Market Size, by End User, 2021–2030 (USD Million)
Table 80 Asia-Pacific: Digital Pathology Market Size, by Country/Region, 2021–2030 (USD Million)
Table 81 Asia-Pacific: Digital Pathology Market Size, by Offering, 2021–2030 (USD Million)
Table 82 Asia-Pacific: Digital Pathology Market Size for Hardware, by Type, 2021–2030 (USD Million)
Table 83 Asia-Pacific: Digital Pathology Market Size for Software, by Type, 2021–2030 (USD Million)
Table 84 Asia-Pacific: Digital Pathology Market Size, by Application, 2021–2030 (USD Million)
Table 85 Asia-Pacific: Digital Pathology Market Size, by End User 2021–2030 (USD Million)
Table 86 China: Digital Pathology Market Size, by Offering, 2021–2030 (USD Million)
Table 87 China: Digital Pathology Market Size for Hardware, by Type, 2021–2030 (USD Million)
Table 88 China: Digital Pathology Market Size for Software, by Type, 2021–2030 (USD Million)
Table 89 China: Digital Pathology Market Size, by Application, 2021–2030 (USD Million)
Table 90 China: Digital Pathology Market Size, by End User 2021–2030 (USD Million)
Table 91 Japan: Digital Pathology Market Size, by Offering, 2021–2030 (USD Million)
Table 92 Japan: Digital Pathology Market Size for Hardware, by Type, 2021–2030 (USD Million)
Table 93 Japan: Digital Pathology Market Size for Software, by Type, 2021–2030 (USD Million)
Table 94 Japan: Digital Pathology Market Size, by Application, 2021–2030 (USD Million)
Table 95 Japan: Digital Pathology Market Size, by End User, 2021–2030 (USD Million)
Table 96 India: Digital Pathology Market Size, by Offering, 2021–2030 (USD Million)
Table 97 India: Digital Pathology Market Size for Hardware, by Type, 2021–2030 (USD Million)
Table 98 India: Digital Pathology Market Size for Software, by Type, 2021–2030 (USD Million)
Table 99 India: Digital Pathology Market Size, by Application, 2021–2030 (USD Million)
Table 100 India: Digital Pathology Market Size, by End User 2021–2030 (USD Million)
Table 101 Rest of Asia-Pacific: Digital Pathology Market Size, by Offering, 2021–2030 (USD Million)
Table 102 Rest of Asia-Pacific: Digital Pathology Market Size for Hardware, by Type, 2021–2030 (USD Million)
Table 103 Rest of Asia-Pacific: Digital Pathology Market Size for Software, by Type, 2021–2030 (USD Million)
Table 104 Rest of Asia-Pacific: Digital Pathology Market Size, by Application, 2021–2030 (USD Million)
Table 105 Rest of Asia-Pacific: Digital Pathology Market Size, by End User, 2021–2030 (USD Million)
Table 106 Latin America: Digital Pathology Market Size, by Country/Region, 2021–2030 (USD Million)
Table 107 Latin America: Digital Pathology Market Size, by Offering, 2021–2030 (USD Million)
Table 108 Latin America: Digital Pathology Market Size for Hardware, by Type, 2021–2030 (USD Million)
Table 109 Latin America: Digital Pathology Market Size for Software, by Type, 2021–2030 (USD Million)
Table 110 Latin America: Digital Pathology Market Size, by Application, 2021–2030 (USD Million)
Table 111 Latin America: Digital Pathology Market Size, by End User, 2021–2030 (USD Million)
Table 112 Brazil: Digital Pathology Market Size, by Offering, 2021–2030 (USD Million)
Table 113 Brazil: Digital Pathology Market Size for Hardware, by Type, 2021–2030 (USD Million)
Table 114 Brazil: Digital Pathology Market Size for Software, by Type, 2021–2030 (USD Million)
Table 115 Brazil: Digital Pathology Market Size, by Application, 2021–2030 (USD Million)
Table 116 Brazil: Digital Pathology Market Size, by End User, 2021–2030 (USD Million)
Table 117 Mexico: Digital Pathology Market Size, by Offering, 2021–2030 (USD Million)
Table 118 Mexico: Digital Pathology Market Size for Hardware, by Type, 2021–2030 (USD Million)
Table 119 Mexico: Digital Pathology Market Size for Software, by Type, 2021–2030 (USD Million)
Table 120 Mexico: Digital Pathology Market Size, by Application, 2021–2030 (USD Million)
Table 121 Mexico: Digital Pathology Market Size, by End User, 2021–2030 (USD Million)
Table 122 Rest of Latin America: Digital Pathology Market Size, by Offering, 2021–2030 (USD Million)
Table 123 Rest of Latin America: Digital Pathology Market Size for Hardware, by Type, 2021–2030 (USD Million)
Table 124 Rest of Latin America: Digital Pathology Market Size for Software, by Type, 2021–2030 (USD Million)
Table 125 Rest of Latin America: Digital Pathology Market Size, by Application, 2021–2030 (USD Million)
Table 126 Rest of Latin America: Digital Pathology Market Size, by End User 2021–2030 (USD Million)
Table 127 Middle East & Africa: Digital Pathology Market Size, by Offering, 2021–2030 (USD Million)
Table 128 Middle East & Africa: Digital Pathology Market Size for Hardware, by Type, 2021–2030 (USD Million)
Table 129 Middle East & Africa: Digital Pathology Market Size for Software, by Type, 2021–2030 (USD Million)
Table 130 Middle East & Africa: Digital Pathology Market Size, by Application, 2021–2030 (USD Million)
Table 131 Middle East & Africa: Digital Pathology Market Size, by End User, 2021–2030 (USD Million)
Table 132 Recent Developments by Major Market Players (2020–2022)
List of Figures
Figure 1 Research Process
Figure 2 Key Secondary Sources
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply-side & Demand-side)
Figure 6 Market Size Estimation
Figure 7 Global Digital Pathology Market Size, by Offering, 2024 Vs. 2030 (USD Million)
Figure 8 Global Digital Pathology Market Size, by Application, 2024 Vs. 2030 (USD Million)
Figure 9 Global Digital Pathology Market Size, by End User, 2024 Vs. 2030 (USD Million)
Figure 10 Global Digital Pathology Market Size, by Geography
Figure 11 Market Dynamics: Digital Pathology Market
Figure 12 Global Digital Pathology Market Size, by Offering, 2024 Vs. 2030 (USD Million)
Figure 13 Global Digital Pathology Market Size, by Application, 2024 Vs. 2030 (USD Million)
Figure 14 Global Digital Pathology Market Size, by End User, 2024 Vs. 2030 (USD Million)
Figure 15 Global Digital Pathology Market Size, by Region, 2024 Vs. 2030 (USD Million)
Figure 16 North America: Digital Pathology Market Snapshot
Figure 17 Europe: Digital Pathology Market Snapshot
Figure 18 Asia Pacific: Digital Pathology Market Snapshot
Figure 19 Latin America: Digital Pathology Market Snapshot
Figure 20 Key Growth Strategies Adopted by Leading Players, 2020–2022
Figure 21 Global Digital Pathology Market: Competitive Benchmarking Based on Product Type
Figure 22 Global Digital Pathology Market: Competitive Benchmarking Based on Geography
Figure 23 Global Digital Pathology Market: Market Share Analysis (2022)
Figure 24 Leica Microsystems (a subsidiary of Danaher Corporation): Financial Overview (2021)
Figure 25 Hamamatsu Photonics K.K.: Financial Overview (2021)
Figure 26 Nikon Corporation: Financial Overview (2021)
Figure 27 Koninklijke Philips N.V.: Financial Overview (2021)
Figure 28 F. Hoffmann-La Roche Ltd: Financial Overview (2021)
Figure 29 PerkinElmer Inc.: Financial Overview (2021)
Author Name:
Proudly Partnering With Enterprises Around the Globe
Quick Contact
Related Reports
Digital Biomanufacturing Market - Global Opportunity Analysis and Industry Forecast (2024-2031)
Published Date: Sep-2024
Digital X-ray Systems Market - Global Opportunity Analysis and Industry Forecast (2024-2031)
Published Date: Jul-2024
Digital Health Market - Global Opportunity Analysis and Industry Forecasts (2024-2031)
Published Date: May-2024
China VNA and PACS Market - Opportunity Analysis and Industry Forecast (2018-2023)
Published Date: Mar-2019
Tissue Diagnostics Market - Global Opportunity Analysis and Industry Forecast (2022-2029)
Published Date: Nov-2022
